U040 Medical and Technological Advancements for the Management of Complex Alopecias
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This session will focus on the rise of emerging technologies for the management of alopecia. The following will be reviewed: artificial intelligence, platelet rich plasma, photobiomodulation (low-level light therapy), hydradermabrasion, hair transplantation, and research in regenerative medicine. Novel regenerative medicine technology will be reviewed. A short pearls talk on the integration of oral minoxidil will close the session. This session will focus on evidence in the literature, product preparation, device characteristics, and current research.
LEARNING OBJECTIVES
Discuss the artificial intelligence for the assessment of alopecia
Discuss the novel medical and procedural technologies available for the management of the alopecia patient
Discuss technological advancements in hair transplantation
SCHEDULE
3:32 PM
Medical management of alopecia: What is on the horizon?
Maria K. Hordinsky, MD, FAAD
3:40 PM
Alopecia procedural management: What is on the horizon?
Neil S. Sadick, MD, FAAD
3:50 PM
Hydradermabrasion: clincal use and the rise of data
Suleima Arruda, MD, IFAAD
3:56 PM
Advancements in hair transplantation
Marc R. Avram, MD, FAAD
4:04 PM
Scientific articles every hair loss dermatologist should know in 2024
Ronda S. Farah, MD, FAAD
4:10 PM
Regenerative medicine- an emerging patient option?
Ana Lucia Junqueira, MD, Ana Carina Junqueira Bertin
SPEAKERS
Suleima Arruda, MD, IFAAD
Marc R. Avram, MD, FAAD
Ronda S. Farah, MD, FAAD
Maria K. Hordinsky, MD, FAAD
Ana Lucia Junqueira, MD
Ana Carina Junqueira Bertin
Neil S. Sadick, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Suleima Arruda, MD, IFAAD
Venus Concept – Consultant(Stock Options);
Marc R. Avram, MD, FAAD
No financial relationships exist with ineligible companies.
Ronda S. Farah, MD, FAAD
American Academy of Dermatology – Other(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Early Sullivan Wright Gizer & McRae LLP – Consultant (1099 relationship)(Fees); Eli Lilly – Investigator(Grants/Research Funding); Novartis – Advisory Board(Fees); Pfizer – Investigator(Grants/Research Funding); Pfizer Inc. – Stockholder(No Compensation Received), Stockholder Public Company(No Compensation Received); Technoderma Medicines – Investigator(Grants/Research Funding);
Maria K. Hordinsky, MD, FAAD
AbbVie – Advisory Board(Fees); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Cassiopea – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); National Alopecia Areata Foundation – Investigator(Grants/Research Funding); RegenLab – Investigator(Grants/Research Funding); Sun Pharmaceuticals – Investigator(Grants/Research Funding); UpToDate, Inc – Other(Fees);
Ana Lucia Junqueira, MD
No financial relationships exist with ineligible companies.
Ana Carina Junqueira Bertin
No financial relationships exist with ineligible companies.
Neil S. Sadick, MD, FAAD
AbbVie – Consultant(Fees); Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding); Acorn Biolabs – Speaker(Honoraria); Advalight – Investigator(Grants/Research Funding), Speaker(Honoraria); Allergan, Inc. – Consultant(Honoraria); Alma Lasers, Inc. – Investigator(Equipment), Investigator(Grants/Research Funding); American Academy of Dermatology – Speaker(No Compensation Received); American Hair Research Society – Board of Directors(No Compensation Received); American Society of Dermatologic Surgery – Speaker(No Compensation Received); Amgen – Investigator(Grants/Research Funding); ASLAN – Investigator(Grants/Research Funding); Aurigene Discovery Technologies Ltd – Independent Contractor(Grants/Research Funding); Bausch Health – Investigator(Grants/Research Funding); Bellus Health – Investigator(Grants/Research Funding); Biorasi, LLC – Investigator(Grants/Research Funding); Biosion – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Canfield Scientific, Inc. – Other(Equipment); Cara Therapeutics – Investigator(Grants/Research Funding); Castle Biosciences – Investigator(Grants/Research Funding); Cell Research Corp – Consultant (1099 relationship)(Honoraria); Celldex – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Corvus Pharmaceuticals – Investigator(Grants/Research Funding); Cutera, Inc. – Other(Equipment), Speaker(Honoraria); Derm Advance – Stockholder(Stock Options); Derm Tech International – Consultant(Fees), Investigator(Grants/Research Funding); Dermira – Investigator(Grants/Research Funding); Distinct Dermatology – Stockholder Private Company(Stock Options); Dr Reddy's Laboratory – Investigator(Grants/Research Funding); Eirion Therapeutics – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); EndyMed Medical Inc. USA – Speaker(Honoraria); Fortrea – Investigator(No Compensation Received); Foundation for Research & Education of Dermatology – Advisory Board(Honoraria), Speaker/Faculty Education(Fees); Galderma USA – Investigator(Grants/Research Funding); Gerson Lehrman Group – Consultant(Honoraria); GlaxoSmithKline Immunology – Investigator(Grants/Research Funding); Highlightll Pharmaceutical – Investigator(Grants/Research Funding); ICON plc. – Investigator(No Compensation Received); IMCAS – Speaker/Faculty Education(Honoraria), Speaker/Faculty Education(Other Financial Benefit); Incyte Corporation – Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); Innovaderm Research Inc. – Investigator(No Compensation Received); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Kadmon Corporation, LLC – Investigator(Grants/Research Funding); Kimera Labs, Inc – Speaker(Honoraria); L'Oreal USA Inc. – Advisory Board(Fees), Consultant (1099 relationship)(Fees); LCN Consulting – Consultant(Fees); LEO Laboratories Ltd (LEO Pharma) – Investigator(Grants/Research Funding); Lumenis Be Ltd. – Consultant(Fees), Investigator(Grants/Research Funding); Lumisque – Speaker(Honoraria); Meiji Seika Pharma Co., Ltd – Investigator(Grants/Research Funding); Merz Aesthetics – Investigator(Grants/Research Funding); Nektar Therapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); NFlection Therapeutics, Inc – Investigator(Grants/Research Funding); Nimbus Therapeutics – Investigator(Grants/Research Funding); NUMAB Therapeutics AG – Investigator(Grants/Research Funding); Paraxel Therapeutics, Inc – Investigator(No Compensation Received); Pfizer Inc. – Investigator(Grants/Research Funding); Philips Healthcare – Investigator(Grants/Research Funding); PPD Inc. – Investigator(Grants/Research Funding); Rho Inc. – Investigator(Grants/Research Funding); Sanofi – Investigator(Equipment), Investigator(Grants/Research Funding); Scientus Pharma Inc. – Stockholder(Stock Options); Shaperon – Investigator(Equipment), Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); Suzhou Connect – Investigator(Grants/Research Funding); Syneos Health – Investigator(No Compensation Received); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); Taylor & Francis – Other(Other Financial Benefit); UCB – Investigator(Equipment), Investigator(Grants/Research Funding); Union Therapeutics – Investigator(Grants/Research Funding); Vanda Pharmaceuticals Inc. – Investigator(Grants/Research Funding); Venus Concept – Investigator(Grants/Research Funding), Other(Equipment), Stockholder(Stock Options); VeraDermics Inc. – Investigator(Grants/Research Funding); Vial – Investigator(No Compensation Received); Vydence Medical – Other(Equipment), Speaker(Honoraria); WeThrivv – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria), Stockholder Private Company(Stock Options);